Try our Advanced Search for more refined results

Biogen Loses Multiple Sclerosis Treatment Patent On Appeal

By Hanna Vioque ( April 22, 2026, 8:40 PM BST) -- European appellate officials have revoked a Biogen patent for a multiple sclerosis treatment, ruling that the pharmaceutical giant had wrongly narrowed its patented claims compared with the more general statements of its first application. ...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies